Income Statement
SBC MEDICAL GROUP HOLDINGS INC
SBC
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Revenue
|
173.61 | 205.42 | - | - |
|
Cost of Revenue
|
13.66 | 8.47 | - | - |
|
Gross Profit
|
127.28 | 156.05 | - | - |
|
Operating Expenses
|
59.80 | 85.75 | 1.64 | 0.00 |
|
Research & Development
|
- | - | - | - |
|
Selling, General & Administrative
|
59.80 | 57.67 | - | - |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
67.49 | 70.30 | -1.64 | - |
|
Non-Operating Income
|
14.58 | 3.15 | -2.50 | - |
|
Interest Income
|
0.20 | 0.02 | - | - |
|
Interest Expense
|
0.15 | 0.03 | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - |
|
Income Before Tax
|
82.07 | 73.46 | 0.87 | - |
|
Income Tax Expense
|
31.08 | 26.84 | 0.53 | - |
|
Non-Controlling Interest
|
0.06 | 0.08 | - | - |
|
Net Income
|
50.99 | 46.61 | 0.34 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
70.17 | 74.10 | -1.64 | 0.00 |
|
Earnings Per Share (Basic)
|
0.50 | 0.48 | 0.04 | - |
|
Diluted EPS
|
0.50 | 0.48 | 0.04 | - |
|
Weighted Average Shares
|
103.00 | 96.56 | 7.84 | - |
|
Diluted Weighted Avg Shares
|
103.00 | 96.56 | 7.90 | - |
|
Comprehensive Income
|
47.87 | 30.01 | - | - |